Time course of detection of viral and serologic markers preceding human immunodeficiency virus type 1 seroconversion: implications for screening of blood and tissue donors

Transfusion

Volumn 35, Issue 2, 1995, Pages 91-97

  BUSCH, M P ^a,c   SATTEN, G A ^b   HENRARD, D R ^b   FARZADEGAN, H ^b   NELSON, K E ^b   READ, S ^b   DODD, R Y ^b   PETERSEN, L R ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Irwin Memorial Blood Centers ^*

^c Blood Centers of the Pacific   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; SCREENING TEST; SEROCONVERSION; SERODIAGNOSIS; VIRUS DETECTION;

BLOOD DONORS; COHORT STUDIES; HIV ANTIBODIES; HIV SEROPOSITIVITY; HIV-1; HIV-2; HUMAN; IMMUNOENZYME TECHNIQUES; MALE; MODELS, THEORETICAL; POLYMERASE CHAIN REACTION; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TIME FACTORS; TISSUE DONORS;

EID: 0028804675     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1046/j.1537-2995.1995.35295125745.x     Document Type: Article

References (50)

1. Serological diagnosis of human immunodeficiency virus infection by Western blot testing
2. Human immunodeficiency virus type 2 infection in the United States Epidemiology, diagnosis, and public health implications
3. Measurement of the false positive rate in a screening program for human immunodeficiency virus infections
4. Performance characteristics of serologic tests for human immunodeficiency virus type 1 (HIV‐1) antibody among Minnesota blood donors. Public health and clinical implications
5. Antibody response in primary human immunodeficiency virus infection
6. Early detection of antibodies to HIV‐1 by third‐generation assays
7. Early detection of antibody to HIV‐1 using an antigen conjugate immunoassay correlates with the presence of IgM antibody
8. Multicenter evaluation of a new recombinant enzyme immunoassay for the combined detection of antibody to HIV‐1 and HIV‐2
9. Duration of human immunodeficiency virus infection before detection of antibody
10. Update: serologic testing for antibody to human immunodeficiency virus
11. Summary of the National Institutes of Health workshop on primary human immunodeficiency virus type 1 infection
12. Transmission of human immunodeficiency virus (HIV) by blood transfusions screened as negative for HIV antibody
13. Exposure of patients to human immunodeficiency virus through the transfusion of blood components that test antibody‐negative
14. Transmission of retroviruses from seronegative donors by transfusion during cardiac surgery. A multicenter study of HIV‐1 and HTLV‐I/II infections
15. Evaluation of screened blood donations for human immunodeficiency virus type 1 infection by culture and DNA amplification of pooled cells
16. Duration of time from onset of HIV‐1 infectiousness to development of detectable antibody. HIV Seroconversion Study Group
17. Transmission of human immunodeficiency virus type 1 from a seronegative organ and tissue donor
18. Prevalence of human immunodeficiency virus type 1 p24 antigen in U.S. blood donors—an assessment of the efficacy of testing in donor screening. HIV‐Antigen Study Group
19. Screening of selected male blood donors for p24 antigen of human immunodeficiency virus type 1. Transfusion Safety Study Group
20. Risk of transmission of HIV by seronegative blood (letter)
21. Human immunodeficiency virus type 1 nucleic acids detected before p24 antigenemia in a blood donor
22. High titers of cytopathic virus in plasma of patients with symptomatic primary HIV‐1 infection
23. Transient high levels of viremia in patients with primary human immunodeficiency virus type 1 infection
24. Viral phenotype and immune response in primary human immunodeficiency viral type 1 infection
25. High levels of HIV‐1 in plasma during all stages of infection determined by competitive PCR
26. Virologic and immunologic characterization of symptomatic and asymptomatic primary HIV‐1 infection
27. Detection of incident HIV infection by PCR compared to serology
28. Detection of human immunodeficiency virus type 1 infection by polymerase chain reaction in a cohort of seronegative intravenous drug users
29. HIV‐1 PCR and isolation in seroconverting and seronegative homosexual men: absence of long‐term immunosilent infection
30. Avoiding false positives with PCR
31. Identification of low‐level contamination of blood as basis for detection of HIV DNA in anti‐HIV‐negative specimens
32. A sensitive viral capture assay for detection of plasma viremia in HIV‐infected individuals
33. Cell‐free plasma human immunodeficiency virus type 1 titer assessed by culture and immunocapture‐reverse transcription‐polymerase chain reaction
34. Reliability of western blotting for the confirmation of HIV‐1 seroconversion (letter)
35. Detection of HIV‐1 p24 antigen and plasma RNA: relevance to indeterminate serologic tests
36. Effectiveness of assays for antibodies to HIV and p24 antigen to detect very recent HIV infections in blood donors. Retrovirus Study Group of the French Society of Blood Transfusion (letter)
37. Evaluation of different supplementary assays for the confirmation of HIV‐1 and HIV‐2 infections (letter)
38. Murine AIDS is initiated in the lymph nodes draining the site of inoculation, and the infected B cells influence T cells located at distance, in noninfected organs
39. Immunopathogenic events in acute infection of rhesus monkeys with simian immunodeficiency virus of macaques
40. Comparative detection of anti‐HIV in early HIV seroconversion
41. Detection of HIV infection among high risk individuals by PCR is frequent preceding antibody conversion but absent in persistently antibody negative persons (abstract).
42. Incidence rates of infectious disease markers in repeat blood donors. NHLBI Retrovirus Epidemiology Donor Study (REDS) (abstract)
43. Unsuspected primary human immunodeficiency virus type 1 infection in seronegative emergency department patients
44. P‐24 HIV antigen screening in donated blood, experience from Thailand (abstract).
45. Infectious disease markers in blood donors in northern Thailand
46. Rapid and simple PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma: application to acute retroviral infection
47. Human immunodeficiency virus type 1 nucleic acids detected before p24 antigenemia in a blood donor
48. Transmission of HIV‐1 from seronegative but PCR‐positive blood donors (letter)